The United States is a leading market for cell therapy instruments, driven by strong investments in regenerative medicine, a growing number of cell therapy clinical trials, and the presence of advanced biotechnology and pharmaceutical companies. The country's robust research infrastructure and increasing focus on personalized medicine continue to support the adoption of sophisticated cell...